Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pediatrix Medical (MD) Restructuring Costs (2019 - 2026)

Pediatrix Medical (MD) has disclosed Restructuring Costs for 7 consecutive years, with $5.9 million as the latest value for Q4 2025.

  • Quarterly Restructuring Costs fell 75.13% to $5.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $22.3 million through Dec 2025, down 65.34% year-over-year, with the annual reading at $22.3 million for FY2025, 65.34% down from the prior year.
  • Restructuring Costs for Q4 2025 was $5.9 million at Pediatrix Medical, down from $6.0 million in the prior quarter.
  • The five-year high for Restructuring Costs was $23.6 million in Q4 2024, with the low at $977000.0 in Q3 2022.
  • Average Restructuring Costs over 5 years is $8.1 million, with a median of $5.9 million recorded in 2025.
  • The sharpest move saw Restructuring Costs crashed 88.66% in 2023, then skyrocketed 965.39% in 2024.
  • Over 5 years, Restructuring Costs stood at $3.1 million in 2021, then surged by 540.16% to $19.6 million in 2022, then plummeted by 88.66% to $2.2 million in 2023, then surged by 965.39% to $23.6 million in 2024, then crashed by 75.13% to $5.9 million in 2025.
  • According to Business Quant data, Restructuring Costs over the past three periods came in at $5.9 million, $6.0 million, and $3.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.